EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,162 | -56.7% | 393,975 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $277,358 | -26.7% | 393,975 | -6.7% | 0.01% | -25.0% |
| Q1 2023 | $378,625 | -100.0% | 422,102 | +90.1% | 0.01% | -62.5% |
| Q3 2022 | $1,672,000,000 | -12.8% | 222,041 | -27.0% | 0.03% | +14.3% |
| Q2 2022 | $1,917,000,000 | +263.8% | 304,300 | +492.0% | 0.03% | +86.7% |
| Q3 2019 | $527,000,000 | – | 51,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |